View Older Stories View More Recent Stories
-
Newfield signs agreements to sell its Texas assets for nearly $390 million
-
Biogen (BIIB) Sale Dependent on Value of Aducanumab - BMO Capital
-
BMO Capital Upgrades Nimble Storage (NMBL) to Outperform
-
Seagate Technology (STX) PT Raised to $31 at BMO Capital
-
The Hanover Insurance Group (THG) PT Trimmed to $94 at BMO Capital
-
BMO Capital Positive on Horizon Pharma (HZNP) Amid CVS/Caremark News; Affirms at 'Outperform'
-
Notable Analyst Rating Changes 8/2: (FORM) (AEO) (PXD) Upgraded; (BWLD) (KR) (WEN) Downgraded
-
Sunstone Partners Expands Investment Team With Five New Hires and One Promotion
-
Chegg (CHGG) Raising PT After Solid Beat - BMO
-
Marsh & McLennan (MMC): Better Consulting Margins Lead to EPS Increase - BMO
-
UPDATE: BMO Capital Downgrades Regal Beloit (RBC) to Market Perform
-
UPDATE: BMO Capital Downgrades HudBay Minerals (HBM) to Market Perform
-
U.S. consumer spending exits second quarter with strong momentum
-
BMO Wealth Management Study: Canadians' Number One Financial Priority is to Reduce or Eliminate Debt
-
Pfizer beats estimates, but branded drugs disappoint
-
BMO Capital Downgrades Kroger (KR) to Market Perform Amid Deflationary Pressures
-
Biogen (BIIB) PT Raised to $304 at BMO Capital
-
Ionis Pharmaceuticals (IONS) PT Raised to $40 at BMO Capital
-
Notable Analyst Rating Changes 8/1: (OAS) (QGEN) (DLTR) Upgraded; (HOG) (AIV) (CTXS) Downgraded
-
Merck (MRK): Good But Not Enough - BMO
-
BMO Financial Group Completes Acquisition of M&A Advisory Firm Greene Holcomb Fisher
-
BMO Capital Upgrades Harley-Davidson (HOG) to Outperform
-
BMO Capital Starts Rigel Pharmaceuticals (RIGL) at Outperform, $4 PT
-
Microsemi (MSCC): Better Guidance Than Expected, Raising PT - BMO
-
Streetinsider.com's Hot Lunchtime Reads 7/29: (WDC) (EPIQ) (ABBV) (ININ)
-
Western Digital (WDC) Marketshare Loss More Important Than EPS Upside - BMO
-
BMO Capital Keeps AbbVie (ABBV) at 'Market Perform'; Says Humira Solid in Q2, but Questions Remain
-
Bunge Limited (BG): Protein Demand to Drive EPS Growth - BMO
-
PotashCorp (POT) This Counts As A Reset But It's Still Too Early To Buy - BMO
-
MasterCard (MA): Raising PT To $128 - BMO
-
BMO Capital Reiterates Outperform on IAC (IAC) Following Mixed 2Q
-
BMO Capital Raises Price Target on Thomson Reuters (TRI) to $60; Reiterates Outperform
-
BMO Capital Remains Bullish on Mead Johnson (MJN) Following 2Q Report
-
BMO Capital Reiterates Outperform on Edison Int'l (EIX) Following EPS Beat
-
UPDATE: BMO Capital Cuts Range Resources (RRC) and Memorial Resource Development (MRD) to Market Perform
-
BMO Capital Downgrades Memorial Resource Development (MRD) to Market Perform
-
CBS Corp. (CBS): Best Mix Shift Opportunity - BMO
-
Amazon.com (AMZN): Returning to Investment in 3Q After Blowing Away Estimates - BMO
-
CN announces US$650-million debt offering
-
PTAB Denial of Amneal's IPR Request for '306 DDI Patent a 'Significant Positive' for Jazz Pharma (JAZZ) - BMO
-
BMO ETF Report: Global Events Promote Growth and Innovation in ETF Industry
-
Piper Jaffray Companies Announces 2016 Second Quarter Results
-
Facebook (FB): Sum Is Greater Than The Parts - BMO
-
Amgen (AMGN) PT Raised to $190 at BMO Capital
-
BMO Capital Downgrades Robert Half (RHI) to Market Perform
-
BMO Capital Downgrades Equity Residential (EQR) to Market Perform
-
Bank of Montreal Announces Dividend Rates on Non-Cumulative 5-Year Rate Reset Class B Preferred Shares, Series 25 and Non-Cumulative Floating Rate Class B Preferred Shares, Series 26
-
BMO Capital Downgrades Tokai Pharmaceuticals (TKAI) to Market Perform
-
BMO Capital Downgrades Tokai Pharmaceuticals (TKAI) to Market Perform
-
UPDATE: BMO Capital Downgrades Noodles & Co. (NDLS) to Market Perform
